Literature DB >> 32559451

Effectiveness of isolation, testing, contact tracing, and physical distancing on reducing transmission of SARS-CoV-2 in different settings: a mathematical modelling study.

Adam J Kucharski1, Petra Klepac2, Andrew J K Conlan3, Stephen M Kissler4, Maria L Tang5, Hannah Fry6, Julia R Gog5, W John Edmunds7.   

Abstract

BACKGROUND: The isolation of symptomatic cases and tracing of contacts has been used as an early COVID-19 containment measure in many countries, with additional physical distancing measures also introduced as outbreaks have grown. To maintain control of infection while also reducing disruption to populations, there is a need to understand what combination of measures-including novel digital tracing approaches and less intensive physical distancing-might be required to reduce transmission. We aimed to estimate the reduction in transmission under different control measures across settings and how many contacts would be quarantined per day in different strategies for a given level of symptomatic case incidence.
METHODS: For this mathematical modelling study, we used a model of individual-level transmission stratified by setting (household, work, school, or other) based on BBC Pandemic data from 40 162 UK participants. We simulated the effect of a range of different testing, isolation, tracing, and physical distancing scenarios. Under optimistic but plausible assumptions, we estimated reduction in the effective reproduction number and the number of contacts that would be newly quarantined each day under different strategies.
RESULTS: We estimated that combined isolation and tracing strategies would reduce transmission more than mass testing or self-isolation alone: mean transmission reduction of 2% for mass random testing of 5% of the population each week, 29% for self-isolation alone of symptomatic cases within the household, 35% for self-isolation alone outside the household, 37% for self-isolation plus household quarantine, 64% for self-isolation and household quarantine with the addition of manual contact tracing of all contacts, 57% with the addition of manual tracing of acquaintances only, and 47% with the addition of app-based tracing only. If limits were placed on gatherings outside of home, school, or work, then manual contact tracing of acquaintances alone could have an effect on transmission reduction similar to that of detailed contact tracing. In a scenario where 1000 new symptomatic cases that met the definition to trigger contact tracing occurred per day, we estimated that, in most contact tracing strategies, 15 000-41 000 contacts would be newly quarantined each day.
INTERPRETATION: Consistent with previous modelling studies and country-specific COVID-19 responses to date, our analysis estimated that a high proportion of cases would need to self-isolate and a high proportion of their contacts to be successfully traced to ensure an effective reproduction number lower than 1 in the absence of other measures. If combined with moderate physical distancing measures, self-isolation and contact tracing would be more likely to achieve control of severe acute respiratory syndrome coronavirus 2 transmission. FUNDING: Wellcome Trust, UK Engineering and Physical Sciences Research Council, European Commission, Royal Society, Medical Research Council.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Year:  2020        PMID: 32559451      PMCID: PMC7511527          DOI: 10.1016/S1473-3099(20)30457-6

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  18 in total

1.  Factors that make an infectious disease outbreak controllable.

Authors:  Christophe Fraser; Steven Riley; Roy M Anderson; Neil M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

2.  Estimating the overdispersion in COVID-19 transmission using outbreak sizes outside China.

Authors:  Akira Endo; Sam Abbott; Adam J Kucharski; Sebastian Funk
Journal:  Wellcome Open Res       Date:  2020-07-10

3.  Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19).

Authors:  Matt J Keeling; T Deirdre Hollingsworth; Jonathan M Read
Journal:  J Epidemiol Community Health       Date:  2020-06-23       Impact factor: 3.710

4.  Contact Tracing Assessment of COVID-19 Transmission Dynamics in Taiwan and Risk at Different Exposure Periods Before and After Symptom Onset.

Authors:  Hao-Yuan Cheng; Shu-Wan Jian; Ding-Ping Liu; Ta-Chou Ng; Wan-Ting Huang; Hsien-Ho Lin
Journal:  JAMA Intern Med       Date:  2020-09-01       Impact factor: 21.873

5.  Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study.

Authors:  Nicholas G Davies; Adam J Kucharski; Rosalind M Eggo; Amy Gimma; W John Edmunds
Journal:  Lancet Public Health       Date:  2020-06-02

6.  What settings have been linked to SARS-CoV-2 transmission clusters?

Authors:  Quentin J Leclerc; Naomi M Fuller; Lisa E Knight; Sebastian Funk; Gwenan M Knight
Journal:  Wellcome Open Res       Date:  2020-06-05

7.  Quantifying SARS-CoV-2 transmission suggests epidemic control with digital contact tracing.

Authors:  Luca Ferretti; Chris Wymant; David Bonsall; Christophe Fraser; Michelle Kendall; Lele Zhao; Anel Nurtay; Lucie Abeler-Dörner; Michael Parker
Journal:  Science       Date:  2020-03-31       Impact factor: 47.728

8.  Spread of SARS-CoV-2 in the Icelandic Population.

Authors:  Daniel F Gudbjartsson; Agnar Helgason; Hakon Jonsson; Olafur T Magnusson; Pall Melsted; Gudmundur L Norddahl; Jona Saemundsdottir; Asgeir Sigurdsson; Patrick Sulem; Arna B Agustsdottir; Berglind Eiriksdottir; Run Fridriksdottir; Elisabet E Gardarsdottir; Gudmundur Georgsson; Olafia S Gretarsdottir; Kjartan R Gudmundsson; Thora R Gunnarsdottir; Arnaldur Gylfason; Hilma Holm; Brynjar O Jensson; Aslaug Jonasdottir; Frosti Jonsson; Kamilla S Josefsdottir; Thordur Kristjansson; Droplaug N Magnusdottir; Louise le Roux; Gudrun Sigmundsdottir; Gardar Sveinbjornsson; Kristin E Sveinsdottir; Maney Sveinsdottir; Emil A Thorarensen; Bjarni Thorbjornsson; Arthur Löve; Gisli Masson; Ingileif Jonsdottir; Alma D Möller; Thorolfur Gudnason; Karl G Kristinsson; Unnur Thorsteinsdottir; Kari Stefansson
Journal:  N Engl J Med       Date:  2020-04-14       Impact factor: 91.245

9.  Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts.

Authors:  Joel Hellewell; Sam Abbott; Amy Gimma; Nikos I Bosse; Christopher I Jarvis; Timothy W Russell; James D Munday; Adam J Kucharski; W John Edmunds; Sebastian Funk; Rosalind M Eggo
Journal:  Lancet Glob Health       Date:  2020-02-28       Impact factor: 26.763

10.  Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

Authors:  Yixiang Ng; Zongbin Li; Yi Xian Chua; Wei Liang Chaw; Zheng Zhao; Benjamin Er; Rachael Pung; Calvin J Chiew; David C Lye; Derrick Heng; Vernon J Lee
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-03-20       Impact factor: 17.586

View more
  239 in total

1. 

Authors:  Ashleigh R Tuite; Amy L Greer
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

2.  Asymptomatic COVID-19 in South Africa - implications for the control of transmission.

Authors:  M Paleker; Y A Tembo; M-A Davies; H Mahomed; D Pienaar; S A Madhi; K McCarthy
Journal:  Public Health Action       Date:  2021-06-21

3.  Shaping the future of the COVID-19 pandemic in Canada.

Authors:  Ashleigh R Tuite; Amy L Greer
Journal:  CMAJ       Date:  2020-08-09       Impact factor: 8.262

4.  Active testing of groups at increased risk of acquiring SARS-CoV-2 in Canada: costs and human resource needs.

Authors:  Jonathon R Campbell; Aashna Uppal; Olivia Oxlade; Federica Fregonese; Mayara Lisboa Bastos; Zhiyi Lan; Stephanie Law; Chi Eun Oh; W Alton Russell; Giorgia Sulis; Nicholas Winters; Mercedes Yanes-Lane; Marc Brisson; Sonia Laszlo; Timothy G Evans; Dick Menzies
Journal:  CMAJ       Date:  2020-09-09       Impact factor: 8.262

5.  The impact of population-wide rapid antigen testing on SARS-CoV-2 prevalence in Slovakia.

Authors:  Stefan Flasche; Sebastian Funk; Martin Pavelka; Kevin Van-Zandvoort; Sam Abbott; Katharine Sherratt; Marek Majdan; Pavol Jarčuška; Marek Krajčí
Journal:  Science       Date:  2021-03-23       Impact factor: 47.728

6.  Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19.

Authors:  Alberto Aleta; David Martín-Corral; Ana Pastore Y Piontti; Marco Ajelli; Maria Litvinova; Matteo Chinazzi; Natalie E Dean; M Elizabeth Halloran; Ira M Longini; Stefano Merler; Alex Pentland; Alessandro Vespignani; Esteban Moro; Yamir Moreno
Journal:  Nat Hum Behav       Date:  2020-08-05

7.  The effectiveness of social bubbles as part of a Covid-19 lockdown exit strategy, a modelling study.

Authors:  Trystan Leng; Connor White; Joe Hilton; Adam Kucharski; Lorenzo Pellis; Helena Stage; Nicholas G Davies; Matt J Keeling; Stefan Flasche
Journal:  Wellcome Open Res       Date:  2021-03-29

8. 

Authors:  Jonathon R Campbell; Aashna Uppal; Olivia Oxlade; Federica Fregonese; Mayara Lisboa Bastos; Zhiyi Lan; Stephanie Law; Chi Eun Oh; W Alton Russell; Giorgia Sulis; Nicholas Winters; Mercedes Yanes-Lane; Marc Brisson; Sonia Laszlo; Timothy G Evans; Dick Menzies
Journal:  CMAJ       Date:  2020-12-07       Impact factor: 8.262

9.  Implication of backward contact tracing in the presence of overdispersed transmission in COVID-19 outbreaks.

Authors:  Akira Endo; Quentin J Leclerc; Gwenan M Knight; Graham F Medley; Katherine E Atkins; Sebastian Funk; Adam J Kucharski
Journal:  Wellcome Open Res       Date:  2021-03-31

10.  Using a household-structured branching process to analyse contact tracing in the SARS-CoV-2 pandemic.

Authors:  Martyn Fyles; Elizabeth Fearon; Christopher Overton; Tom Wingfield; Graham F Medley; Ian Hall; Lorenzo Pellis; Thomas House
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2021-05-31       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.